InBrain Pharma
Business Services · France · 1-10 Employees
View Company Info for Free
Overview
Headquarters
70 Rue Du Docteur Yersin, Loos, Hauts-de...Website
www.inbrainpharma.comRevenue
<$5 MillionIndustry
About InBrain Pharma
Is InBrain Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
InBrain Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at InBrain Pharma
Check out if InBrain Pharma is spiking on competitors!
Check if InBrain Pharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when InBrain Pharma launches new products
Click to see if InBrain Pharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once InBrain Pharma has new funding data
Earning: See what the market has to say on InBrain Pharma recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
InBrain Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
InBrain Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about InBrain Pharma.
InBrain Pharma Tech Stack
A closer look at the technologies used by InBrain Pharma
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding InBrain Pharma
InBrain Pharma is a biotechnology company focused on the infusion of drugs for the management of neurological disorders, particularly in the context of Parkinson's disease. The company aims to provide innovative therapies, such as A-Dopamine, to patients who are refractory to traditional L-dopa treatments. Their target clients include healthcare pr... Read More